MetaCap

Who Owns Rigel Pharmaceuticals Stock?

NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

40.09-1.10 (-2.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
95.16%
Institutional holders
248
  • Institutions 95.2%
  • Insiders 3.3%
  • Public and other 1.5%

Who owns Rigel Pharmaceuticals stock?

Institutional investors own about 95.2% of Rigel Pharmaceuticals's shares, spread across 248 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.33% of RIGL.

The largest institutional holders are Blackrock Inc. (10.97%), Soleus Capital Management, L.P. (9.79%) and Armistice Capital, LLC (8.16%). Together, the top 10 institutions control 59.5% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their RIGL positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of RIGL

Rigel Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.2.07M10.97%+6.5%
Soleus Capital Management, L.P.1.84M9.79%0.0%
Armistice Capital, LLC1.54M8.16%-8.1%
Morgan Stanley1.26M6.67%+575.5%
American Century Companies Inc1.04M5.54%+40.8%
State Street Corporation879.86K4.67%-15.4%
LSV Asset Management787.41K4.18%+9.1%
Vanguard Capital Management LLC782.70K4.16%-0.3%
Assenagon Asset Management S.A.535.68K2.84%+100.0%
Geode Capital Management, LLC482.98K2.56%-0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of RIGL

Rigel Pharmaceuticals top fund holders
FundShares% Held
American Century ETF Trust-Avantis U.S. Small Cap Value ETF873.24K4.64%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund555.85K2.95%
iShares Trust-iShares Russell 2000 ETF477.54K2.54%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF473.80K2.52%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund212.41K1.13%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund201.87K1.07%
iShares Trust-iShares Russell 2000 Value ETF170.06K0.90%
Delaware Group Equity Funds IV-Nomura Healthcare Fund160.00K0.85%
iShares Trust-iShares Biotechnology ETF141.63K0.75%
BlackRock Funds-BlackRock Advantage Small Cap Core Fund110.57K0.59%

Frequently asked questions

Who is the largest shareholder of Rigel Pharmaceuticals?

Blackrock Inc. is the largest institutional shareholder of RIGL, owning 10.97% of shares outstanding (2.07M shares) as of its latest 13F filing.

What percentage of Rigel Pharmaceuticals is owned by institutions?

Institutions own about 95.2% of RIGL shares and 98.4% of the public float.

How much of Rigel Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 3.33% of RIGL shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related